Prestige Consumer Healthcare Inc (PBH)
70.44
+0.12
(+0.17%)
USD |
NYSE |
May 10, 16:00
70.44
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Cash from Investing (TTM): -11.46M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -11.46M |
September 30, 2023 | -8.772M |
June 30, 2023 | -8.214M |
March 31, 2023 | -11.58M |
December 31, 2022 | -8.519M |
September 30, 2022 | -26.94M |
June 30, 2022 | -256.24M |
March 31, 2022 | -256.51M |
December 31, 2021 | -258.11M |
September 30, 2021 | -243.61M |
June 30, 2021 | -21.01M |
March 31, 2021 | -22.24M |
December 31, 2020 | -25.61M |
September 30, 2020 | -22.37M |
June 30, 2020 | -17.17M |
March 31, 2020 | -16.57M |
December 31, 2019 | -11.65M |
September 30, 2019 | -11.23M |
June 30, 2019 | 55.94M |
March 31, 2019 | 55.43M |
December 31, 2018 | 55.90M |
September 30, 2018 | 53.09M |
June 30, 2018 | -12.45M |
March 31, 2018 | -11.56M |
December 31, 2017 | -813.57M |
Date | Value |
---|---|
September 30, 2017 | -749.43M |
June 30, 2017 | -695.28M |
March 31, 2017 | -694.60M |
December 31, 2016 | -117.73M |
September 30, 2016 | -170.61M |
June 30, 2016 | -223.43M |
March 31, 2016 | -222.97M |
December 31, 2015 | 2.64M |
September 30, 2015 | 3.94M |
June 30, 2015 | -727.21M |
March 31, 2015 | -805.26M |
December 31, 2014 | -802.96M |
September 30, 2014 | -810.98M |
June 30, 2014 | -135.10M |
March 31, 2014 | -57.98M |
December 31, 2013 | -59.22M |
September 30, 2013 | -40.83M |
June 30, 2013 | 11.27M |
March 31, 2013 | 11.22M |
December 31, 2012 | -650.48M |
September 30, 2012 | -668.58M |
June 30, 2012 | -663.54M |
March 31, 2012 | -662.21M |
December 31, 2011 | -76.51M |
September 30, 2011 | -278.66M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-258.11M
Minimum
Dec 2021
55.94M
Maximum
Jun 2019
-62.20M
Average
-17.17M
Median
Jun 2020
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |
Theriva Biologics Inc | -0.202M |
Oragenics Inc | -0.9363M |